Medication info
Clopidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Clopidogrel Tablets (Clopidogrel Hydrogen Sulfate)

Prescription medicationTabletOral
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201207510 · Approved 2012.10.30 · Insurance code 657305790

Summary

Main use
Improvement of acute coronary syndrome and atherosclerotic symptoms; prevention of thromboembolism in atrial fibrillation
Who takes it
Adults
Adult dose
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine orally once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of acute coronary syndrome and atherosclerotic symptoms; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular anomalies
  • stroke
  • refractory ischemia
  • vascular risk factors
  • atherosclerotic thrombosis
  • thromboembolism
View approved original text

This medication is used to improve symptoms caused by atherosclerosis in adults with ischemic stroke, myocardial infarction, or peripheral arterial disease. It also improves atherosclerotic-related symptoms such as mortality from cardiovascular events, myocardial infarction, and stroke in adult patients with acute coronary syndrome, particularly those with unstable angina or non-Q-wave myocardial infarction who have undergone therapy such as medication treatment, coronary intervention, or coronary artery bypass surgery. Additionally, it helps reduce the risk of stroke and thromboembolism in adult patients with atrial fibrillation, where vitamin K antagonists are not suitable, and the risk of bleeding is low. Thus, it effectively lowers a variety of cardiovascular diseases and thrombotic-related risks for the improvement of patients' health.

How to take

Adult dose

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this medicine orally once daily on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be administered concomitantly with this medicine once daily. 3. For patients with atrial fibrillation, administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be administered concomitantly with this medicine once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medicine may be administered with or without food.

Precautions

This drug prevents platelets in the blood from clumping together, thereby preventing blood from clotting. Individuals with genetically reduced function of a specific enzyme (CYP2C19) may experience diminished effectiveness of this drug. In such cases, the physician may consider other treatment options. Taking this drug with certain medications (CYP2C19 inducers) may enhance its effects excessively, increasing the risk of bleeding, so it is advisable not to combine them. Patients who are allergic to this drug, have severe bleeding, severely impaired liver function, are nursing, or have lactose intolerance should not use it. Patients at high risk for bleeding or those scheduled for surgery should stop taking this drug or use it with caution, and any signs of bleeding must be reported immediately to a healthcare professional. Particularly, when used with other medications that affect blood coagulation, the risk of bleeding may increase, so caution is advised. During treatment with this drug, bleeding may take longer to stop, so if there is a bleeding site or if bleeding persists for a long time, consult your doctor immediately. It is important to periodically check platelet levels or whether there is bleeding through blood tests. This medication has not been established for safety and efficacy in children, so it is not to be used in pediatric patients. Women who are pregnant or nursing must consult their physician before taking this medication, and if they are close to their delivery date, they may need to stop taking it to reduce the risk of bleeding. Overdosage may result in increased bleeding, and since there is no specific antidote, immediate hospital treatment is necessary. Store this drug out of reach of children, and it is preferable not to transfer it to another container.

Side effects

  • Hemorrhage
  • gastrointestinal bleeding
  • hospitalization-required bleeding
  • purpura
  • contusion
  • hematoma
  • nasal bleeding
  • hematoma
  • hematuria
  • intraocular hemorrhage
Show 105 more
  • intracranial hemorrhage
  • major bleeding
  • minor bleeding
  • severe bleeding
  • fatal bleeding
  • hemorrhagic stroke
  • thrombocytopenia
  • neutropenia
  • aplastic anemia
  • gastrointestinal symptoms
  • abdominal pain
  • indigestion
  • diarrhea
  • nausea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • depression
  • upper respiratory tract infection
  • shortness of breath
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • decreased motor function
  • tremor
  • voice disorder
  • abnormal gait
  • hyperkinesia
  • ataxia
  • sensory disturbance
  • constipation
  • vomiting
  • ulcer
  • abdominal pain
  • loss of appetite
  • hiccups
  • dry mouth
  • dysphagia
  • tongue disease
  • insomnia
  • depression
  • forgetfulness
  • anxiety
  • altered mental state
  • abnormal behavior
  • rigidity
  • facial edema
  • syncope
  • purpura
  • bloody stool
  • hematoma
  • hematuria
  • hemoptysis
  • muscle hemorrhage
  • gingival bleeding
  • anemia
  • cough
  • shortness of breath
  • visual disturbances
  • field defects
  • dry eyes
  • transient blindness
  • congestion
  • tinnitus
  • taste disorder
  • loss of taste
  • vasculitis
  • hypotension
  • bronchospasm
  • interstitial pneumonia
  • eosinophilic pneumonia
  • colitis
  • pancreatitis
  • gastritis
  • stomatitis
  • hepatitis
  • acute liver failure
  • papular rash
  • erythematous skin rash
  • urticaria
  • itching
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • arthralgia
  • arthritis
  • myalgia
  • glomerulonephritis
  • gynecomastia
  • fever
  • abnormal liver function tests
  • increased blood creatinine
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This drug must be stored in a tightly sealed container to prevent air or moisture from entering. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage will maintain the drug's efficacy and safety for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.